SCHEMBL13636976

SCHEMBL13636976

CCc1cc(C)cc(C(C)CC)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
ALOX15 P16050 2/20 0.40
ALOX12 P18054 1/20 0.40
RORC P51449 1/20 0.39
AMY1A P0DUB6 1/20 0.34
HSPA5 P11021 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
NR3C1 P04150 1/20 0.33
PGR P06401 1/20 0.33
NR3C2 P08235 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6943323 0.86 TSHR (0.48) TSHRALOX15RORCHDAC4HDAC2
SCHEMBL25274613 0.85 CA1 (0.45) ALOX15ALOX12AMY1AHSPA5GABRA1
SCHEMBL12457769 0.83 HTT (0.38) TSHRALOX15RORCSMN1; SMN2ALDH1A1
SCHEMBL8760785 0.81 TSHR (0.44) TSHRALOX15RORCHDAC4HDAC2
SCHEMBL14557201 0.81 TSHR (0.44) TSHRALOX15RORCHDAC4HDAC2
SCHEMBL4549116 0.81 CA1 (0.50) TSHRRORCGABRA1GABRB2HIF1A
SCHEMBL12457777 0.78 AMY1A (0.41) TSHRRORCAMY1AHSPA5CYP2C9
SCHEMBL14344951 0.78 CA1 (0.47) TSHRALOX15ALOX12RORCHDAC4
SCHEMBL310746 0.77 ERN1 (0.58) TSHRRORC
SCHEMBL45859 0.77 GABRA1 (0.52) ALOX15ALOX12AMY1AHSPA5GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2123312-A2 Extraction of solvents from drug containing polymer reservoirs Cordis Corporation (US) 2009-11-25 EP disclosed
EP-2042202-A2 Local vascular delivery of mTor inhibitors in combination with peroxisome proliferators-activated receptor stimulators Cordis Corporation (US) 2009-04-01 EP disclosed